Enalees Unicorn Score: 77/100
Biotechnologyenalees.com
Enalees develops, manufactures, and markets rapid molecular diagnostic tests for veterinarians to detect infectious diseases in canine, feline, and equine animals.
77/100
High PotentialBuy
Valuation track record
- First screened
- Apr 7, 2026
- Entry valuation
- Undisclosed
- Current valuation
- Undisclosed
Get the full Enalees report
Founders deep-dive, traction signals, market thesis, red flags, scoring breakdown and an audio summary, delivered to your inbox.
Frequently asked
What is Enalees's unicorn score?
Enalees has a Unicorn Screener score of 77/100, classified as "High Potential". Recommended action: buy.
What is Enalees's current valuation?
Enalees has no publicly disclosed valuation on file. Unicorn Screener tracks valuations from public funding announcements only and does not publish private estimates.
What sector is Enalees in?
Enalees operates in the Biotechnology sector.
When was Enalees first screened?
Enalees was first screened by Unicorn Screener on Apr 7, 2026.